U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9222192221Intervention Study to Improve Antibiotic Prescription in Outpatient CareCompletedNo Results AvailableRespiratory Tract Infections|Urinary Tract InfectionsOther: Mailing of antibiotic therapy guidelines to the sentinel physicianshttps://ClinicalTrials.gov/show/NCT01358916
9222292222A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: RO5429083|Drug: RO5429083https://ClinicalTrials.gov/show/NCT01358903
9222392223Low-Carbohydrate Diet Intervention on Body WeightCompletedNo Results AvailableOver Weight|ObesityOther: low carbohydrate diet|Other: Calories restricted diethttps://ClinicalTrials.gov/show/NCT01358890
9222492224A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Chemotherapy|Drug: pertuzumab|Drug: placebo|Drug: trastuzumab [Herceptin]https://ClinicalTrials.gov/show/NCT01358877
9222592225Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)CompletedNo Results AvailableHepatitis C, ChronicDrug: BI 201335|Drug: Pegylated Interferon-alpha (IFN)|Drug: Ribavirin (RBV)|Drug: Pegylated Interferon-alpha (IFN)|Drug: Pegylated Interferon-alpha (IFN)|Drug: BI 201335|Drug: Ribavirin (RBV)|Drug: Ribavirin (RBV)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01358864
9222692226LAS41005 in Hyperkeratotic Actinic KeratosisCompletedNo Results AvailableActinic KeratosisProcedure: Cryotherapy|Drug: LAS41005https://ClinicalTrials.gov/show/NCT01358851
9222792227Ablative 10600 nm Fractional Laser Therapy for the Treatment of ScarsCompletedNo Results AvailableScarsDevice: ablative 10600 nm fractional laser therapyhttps://ClinicalTrials.gov/show/NCT01358838
9222892228Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexaâ„¢ or Infanrix-IPV/Hibâ„¢CompletedNo Results AvailablePoliomyelitis|Diphtheria|Hepatitis B|Haemophilus Influenzae Type b Disease|Pertussis|TetanusProcedure: Blood Samplinghttps://ClinicalTrials.gov/show/NCT01358825
9222992229FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal CancerCompletedNo Results AvailableMetastatic Colo-rectal CancerDrug: FOLFOXIRI + Panitumumabhttps://ClinicalTrials.gov/show/NCT01358812
9223092230Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ SystemWithdrawnNo Results AvailableChlamydia TrachomatisDevice: APTIMA Assay for Chlamydia trachomatishttps://ClinicalTrials.gov/show/NCT01358799
9223192231Seroma at the Donor Site of the TRAM Flap, With or Without Quilting Suture: A Comparative Study Using UltrasoundCompletedNo Results AvailableSeromaProcedure: quilting suturehttps://ClinicalTrials.gov/show/NCT01358786
9223292232The Effect of 1 Year of Multiprofessional Therapy on ObesityRecruitingNo Results AvailableObesityOther: multidisciplinary interventionhttps://ClinicalTrials.gov/show/NCT01358773
9223392233Dehydroepiandrosterone (DHEA) Against Vaginal AtrophyCompletedNo Results AvailableVaginal AtrophyDrug: Placebo|Drug: DHEA|Drug: DHEAhttps://ClinicalTrials.gov/show/NCT01358760
9223492234Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HLCompletedNo Results AvailableHodgkin's LymphomaDrug: BEACOPPesc|Drug: BEACOPPesc - ABVD - PET2https://ClinicalTrials.gov/show/NCT01358747
9223592235A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly SubjeActive, not recruitingNo Results AvailableAcute Myeloid Leukemia|Acute Myelogenous LeukemiaDrug: Azacitidine-single agent|Drug: Lenalidomide - single agent|Drug: Lenalidomide in combination with azacitidinehttps://ClinicalTrials.gov/show/NCT01358734
9223692236Phase I Biomarker Study (BMS-936558)Active, not recruitingNo Results AvailableRenal Cell CarcinomaDrug: BMS-936558 (Anti-PD-1)|Drug: BMS-936558 (Anti-PD-1)|Drug: BMS-936558 (Anti-PD-1)https://ClinicalTrials.gov/show/NCT01358721
9223792237Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mgTerminatedHas ResultsDiarrhea-predominant Irritable Bowel SyndromeDrug: LACTEOL® 340 mg|Drug: PLACEBOhttps://ClinicalTrials.gov/show/NCT01358708
9223892238Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's FeetCompletedNo Results AvailableLateral Canthal Lines|Crow's FeetBiological: ANT-1207|Biological: Botulinum Toxin, Type A|Biological: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT01358695
9223992239[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01358682
9224092240Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip ArthroplastyRecruitingNo Results AvailableRevision Surgery of Total Hip ArthroplastyDrug: Denosumab|Other: Placebohttps://ClinicalTrials.gov/show/NCT01358669
9224192241Anterior Cruciate Ligament Reconstruction Using Single Bundle and Double Bundle TechniquesRecruitingNo Results AvailableAnterior Cruciate Ligament InjuryProcedure: Single bundle anterior cruciate ligament reconstruction|Procedure: Double bundle anterior cruciate ligament reconstructionhttps://ClinicalTrials.gov/show/NCT01358656
9224292242Operations Enduring Freedom and Iraqi Freedom (OEF/OIF)Veteran Preferences for Automated Physical Activity InterventionsEnrolling by invitationNo Results AvailablePhysical ActivityOther: Three home-based diet and exercise programshttps://ClinicalTrials.gov/show/NCT01358643
9224392243Vascular and Periodontal Disease - Microbial, Genetic and Histological CausalitiesRecruitingNo Results AvailablePeriodontitis|Vascular Diseasehttps://ClinicalTrials.gov/show/NCT01358630
9224492244Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With NeuroblastomaCompletedNo Results AvailableDisseminated Neuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Stage 4S NeuroblastomaOther: diagnostic laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01358617
9224592245Biomarkers in Samples From Young Patients With NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaGenetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: western blotting|Other: flow cytometry|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01358604
9224692246Effect of a High Calcium Breakfast on Exercise Metabolism and AppetiteCompletedNo Results AvailableExercise Fat OxidationDietary Supplement: High calcium milk|Dietary Supplement: Controlhttps://ClinicalTrials.gov/show/NCT01358591
9224792247Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type PsoriasisCompletedHas ResultsChronic Plaque PsoriasisDrug: Placebo|Drug: secukinumab (AIN457)|Drug: etanercepthttps://ClinicalTrials.gov/show/NCT01358578
9224892248Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic DysfunctionCompletedNo Results AvailableMild Hepatic Dysfunction|Moderate Hepatic DysfunctionDrug: Fx-1006A|Drug: Fx-1006Ahttps://ClinicalTrials.gov/show/NCT01358565
9224992249Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)TerminatedNo Results AvailablePregnancyOther: Néevo®/ NéevoDHA®https://ClinicalTrials.gov/show/NCT01358552
9225092250Palliation: the Effect of Education on PainRecruitingNo Results AvailableBone MetastasesBehavioral: Pain educationhttps://ClinicalTrials.gov/show/NCT01358539

* Görseller ve İçerik tekif hakkına sahip olabilir